FDA Asked, Sarepta Refused To Stop Elevidys Shipments After Third Death With Gene Therapy Vector

DMD Product Under Agency Investigation Since June 24

 
• By Mandy Jackson
  
The FDA began investigating Elevidys in June after a second DMD patient died from acute liver failure (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies